WIRED
Wired.com is the website of monthly magazine Wired. Its content focuses on the intersection of technology with culture, business and human nature. According to its About page, its goal is to produce "information and ideas that make sense of a world in constant transformation." It is owned by Condé Nast Inc. Its editor in chief is Nicholas Thompson. Wired's AllSides Media Bias Rating™ was changed from Lean Left to Center in February 2020. At the time it was changed, the initial rating had been voted on 163 times by community members, with 85 disagreeing.
Type of Content
Approved Story
1
Format
Region
News Item Format
Standard
Image Caption
JORDAN VONDERHAAR/BLOOMBERG/GETTY IMAGES
Autocurated
0
Elon Musk said on the social media platform X on Monday that the first human patient has received a brain implant developed by his company Neuralink. The product also now has a name: Telepathy.
After years of delays, Neuralink started recruiting patients for a clinical trial in the fall after receiving approval from the US Food and Drug Administration and a hospital ethics board. The company is developing a device called a brain-computer interface.
Musk has said that Neuralink’s ultimate goal is to "achieve a symbiosis with artificial intelligence," but for now he’s starting with a far more modest aim: allowing paralyzed people to control a cursor or keyboard with their brains. In a brochure about the study, Neuralink says it is recruiting participants with quadriplegia, or paralysis in all four limbs, due to cervical spinal cord injury or amyotrophic lateral sclerosis (ALS) and that are at least 22 years old. It anticipates the study will take six years to complete.